Project Number 5U01AG058608-02 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Silent Allosteric Modulation of mGluR5 for Safe and Effective Therapy of Alzheimers Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator STRITTMATTER, STEPHEN M Principal Investigator First Name STEPHEN Principal Investigator Last Name STRITTMATTER Awardee Organization YALE UNIVERSITY Awardee State Connecticut Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-15-174: Alzheimer's Drug-Development Program (U01) FY Overall Cost $1,657,941 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA
